F.D.A. Approves Studies of Pig Organ Transplants for Kidney Patients
February 3, 2025

(New York Times) – The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ transplant.
The U.S. Food and Drug Administration has given the green light to two biotechnology companies for clinical trials that will transplant organs from genetically modified pigs into people with kidney failure. If successful, these studies could lead to the broader use of cross-species transplantation, a dream of medical scientists for centuries.
One of the companies, United Therapeutics Corporation, will begin its trial with six patients, but that number could eventually rise to 50. The other, eGenesis, said it would begin with three patients and grow the study from there. (Read More)